| 5R01MH114966-05 |
2021 |
$290052 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
| 5R01MH114966-04 |
2020 |
$288670 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
| 5R01MH114966-03 |
2019 |
$362557 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
| 3R01MH114966-03S1 |
2019 |
$94826 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
| 5R01MH114966-02 |
2018 |
$313299 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
| 1R01MH114966-01 |
2017 |
$305389 |
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depression |
